ResMed (NYSE:RMD) Director Sells $502,620.00 in Stock

robot
Abstract generation in progress

ResMed (NYSE:RMD) Director Peter Farrell sold 2,000 shares of the company stock worth $502,620 on February 4th, reducing his stake by 3% to 64,773 shares. This transaction follows a strong quarter for ResMed, where it exceeded EPS estimates and reported an 11% year-over-year revenue increase. The company also declared a quarterly dividend of $0.60 and maintains a “Moderate Buy” consensus rating from analysts with an average target price of $299.27.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)